Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine composition for treating bartholinitis and preparation method thereof

A bartholinitis and composition technology, which is applied in the direction of drug combination, pharmaceutical formula, phosphorus compound active ingredients, etc., can solve the problems of repeated abscess attack, repeated infection, and poor discharge of pus in the fistula, and achieve drug resistance. , Relieve the patient, the curative effect is remarkable

Inactive Publication Date: 2016-03-23
李艳红
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, western medicine treatment mainly uses antibiotics, which can easily cause allergies or drug resistance; for abscess formation, surgery is generally used, incision and drainage and ostomy, but simple incision and drainage can only temporarily relieve symptoms. After the incision is closed, Cysts or repeated infections may still form, and if the incision is not large enough, it will lead to poor drainage of pus, resulting in fistula formation or repeated abscess attacks; in addition, there are other special treatments such as local hot compress, infrared or microwave physiotherapy, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] A pharmaceutical composition for treating bartholinitis, which is prepared from the following raw materials in proportions by weight: 100 parts of lettuce seeds, 80 parts of Xiangcao tree, 60 parts of thirteen years flower, 50 parts of sorghum seven, 40 parts of chrysanthemum, 40 parts of longan root, 30 parts of starling wood, 20 parts of terrapin gum, 6 parts of madder, 5 parts of flower on the leaf, 5 parts of clematis, 3 parts of black cumin, 3 parts of dendrobium, 3 parts of lemon, 30 parts of maltose, 5 parts of glucuronolactone, 5 parts of amino acid mixture, 3 parts of α-pinene, 3 parts of biotin, 2 parts of niacin, 2 parts of minerals, and 1 part of antibacterial agent.

[0044] Wherein, the amino acid mixture is a mixture formed by combining L-glutamic acid, L-alanine, and glycine in a weight ratio of 1:2:2. The minerals include the following components: potassium, calcium, zinc, magnesium, copper, manganese, phosphorus and selenium. The antibacterial agent i...

Embodiment 2

[0051] A pharmaceutical composition for treating bartholinitis, which is prepared from the following raw materials in proportions by weight: 600 parts of lettuce seeds, 400 parts of Xiangcao tree, 300 parts of thirteen years flower, 200 parts of sorghum seven, 200 parts of chrysanthemum, 100 parts of longan root, 100 parts of starling wood, 100 parts of terrapin glue, 30 parts of madder, 25 parts of flowers on leaves, 25 parts of clematis, 20 parts of nigella seed, 10 parts of dendrobium, 10 parts of lemon, 80 parts of maltose, 10 parts of glucuronolactone, 10 parts of amino acid mixture, 5 parts of α-pinene, 5 parts of biotin, 3 parts of niacin, 2.5 parts of minerals, 1.2 parts of antibacterial agent.

[0052] Wherein, the amino acid mixture is a mixture formed by combining L-glutamic acid, L-alanine, and glycine in a weight ratio of 1:2:2. The minerals include the following components: potassium, calcium, zinc, magnesium, copper, manganese, phosphorus and selenium. The anti...

Embodiment 3

[0059] A pharmaceutical composition for treating bartholinitis, which is prepared from the following raw materials in proportions by weight: 1050 parts of lettuce seeds, 840 parts of Xiangcao tree, 780 parts of thirteen years flower, 775 parts of sorghum seven, 620 parts of chrysanthemum, 520 parts of longan root, 465 parts of starling wood, 410 parts of terrapin gum, 253 parts of madder, 202.5 parts of flowers on leaves, 52.5 parts of clematis, 31.5 parts of black cumin, 26.5 parts of dendrobium, 21.5 parts of lemon, 115 parts of maltose, 22.5 parts of glucuronolactone, 12.5 parts of amino acid mixture, 6.5 parts of α-pinene, 6.5 parts of biotin, 3.5 parts of niacin, 3 parts of minerals, and 1.5 parts of antibacterial agent.

[0060] Wherein, the amino acid mixture is a mixture formed by combining L-glutamic acid, L-alanine, and glycine in a weight ratio of 1:2:2. The minerals include the following components: potassium, calcium, zinc, magnesium, copper, manganese, phosphorus...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine composition for treating bartholinitis and a preparation method thereof, and relates to the technical field of medicaments of the obstetrics and gynecology department. The medicine composition for treating bartholinitis is prepared from lettuce seeds, machilus grifsii Hance, colla carapacis trionycis, roots and leaves of affined conehead, rhizomes of sorghumpro pinquum (Kunth) Hitehc., lip-fern, roots of long pepper, wood of largeleaf dogwood, herba rubiae yunnanensis, helwingia japonica (Thunb.) Dietr., roots of Szechwan-Yunnan sanicle, semen nigellae, dendrobe, lemons, maltose, glucuronolactone, an amino acid mixture, alpha-pinene, biotin, niacin, mineral matter and an antibacterial agent. The medicine composition is prepared according to the theory of traditional Chinese medicine in combination with clinical experience, the selected medicinal materials are reasonable in compatibility and appropriate in proportion, all the ingredients supplement one another and jointly achieve the effects of clearing away heat and toxic materials, dispersing stasis and diminishing swelling, promoting blood circulation and alleviating pain, tonifying Qi and reinforcing deficiency, resisting bacteria and diminishing inflammation, clearing away liver heat, tonifying middle-Jiao and Qi and tonifying the stomach and promoting fluid, and the medicine composition can effectively treat bartholinitis and thoroughly remove the disease and is significant in treatment effect, not likely to cause medicine resistance and small in side effect.

Description

technical field [0001] The invention relates to the technical field of obstetrics and gynecology pharmaceuticals, in particular to a pharmaceutical composition for treating Bartholinitis and a preparation method thereof. Background technique [0002] Bartholinitis is inflammation of the Bartholin gland. The Bartholin glands are located in the lower 1 / 3 of the labia majora on both sides, with a diameter of about 0.5-1.0 cm, and their outlet ducts are about 1.5-2.0 cm long, and the opening of the glands is located on the inner side of the labia minora near the hymen. Due to the particularity of the anatomical location, when the vulva is contaminated during sexual intercourse, childbirth and other situations, pathogens can easily invade and cause Bartholinitis. The disease is often a mixed infection with complex pathogens, and the main pathogens are endogenous pathogens and pathogens of sexually transmitted diseases. Staphylococcus, Streptococcus, Escherichia coli, Neisseria ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/47A61P15/00A61K36/28A61K36/54A61K36/19A61K36/899A61K36/11A61K36/67A61K36/40A61K35/586A61K36/74A61K36/185A61K36/45A61K36/80A61K36/71A61K36/8984A61K36/752A61K31/7016A61K31/155A61K31/7048A61K31/198A61K31/015A61K31/4188A61K31/455A61K33/00A61K33/06A61K33/30A61K33/34A61K33/32A61K33/42A61K33/04
CPCA61K9/1623A61K9/2031A61K9/28A61K9/485A61K31/015A61K31/155A61K31/198A61K31/4188A61K31/455A61K31/7016A61K31/7048A61K33/00A61K33/04A61K33/06A61K33/30A61K33/32A61K33/34A61K33/42A61K35/586A61K36/11A61K36/185A61K36/19A61K36/28A61K36/40A61K36/45A61K36/54A61K36/67A61K36/71A61K36/74A61K36/752A61K36/80A61K36/8984A61K36/899A61K38/47A61K47/26A61K2236/33A61K2236/331A61K2300/00
Inventor 李艳红王俊红孙秀莲
Owner 李艳红
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products